CSIR sanctions project to develop human monoclonal antibodies as therapy for COVID-19 infections Read more
Syntegon building on stable business performance and implementing new measures during the coronavirus crisis Read more
Ratan Tata invests in 18-year-old’s Generic Aadhaar to bring affordable medicines to masses Read more